Neurology

Notizia - Recent Pharma, Healthcare and Biotech Happenings

PAVmed-Novosound’s Partnership; J&J Acquires Abiomed; Approval to Sysmex’s Assay Kit to Identify Amyloid Beta (Aβ) Accumulation; SI-BONE Announced FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite Implant System; EOFlow’s Wearable Insulin Pump ‘EOPatch’; Icecure’s ProSense System, a Cryoablation Therapy

PAVmed Entered into a Partnership with Novosound for Ultrasound Imaging Technology On December 22, 2022, PAVmed Inc., a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, announced that the company has entered into a partnership with Novosound Ltd., a venture-backed technology company based in Glasgow, Scotland. The partnership is done to explore Novosound’s proprietary flexible thin-film ultrasound technology in medical imaging, initially targeting next-generation intravascular ultrasound (IVUS) imaging. Under this agreement, PAVmed and Novosound will work together on a joint ...

Explore More...

sleep-disorders-market-symptoms-risk-factors-types-and-treatment-options

Sleep Disorders: An Emerging Public Health Issue

Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?

recent-pharma-news-update-happenings-for-amgen-rodeo-novartis-organon-alydia-forma

Amgen to acquire Rodeo for $55M; Novartis expands radioligand portfolio; Organon acquires Alydia for $240M; Forma announces positive FT-4202 dose levels

depression-signs-symptoms-risk-factors-types-treatment-options

How Depression Is Eroding The Mental And The Physical Health Of The Society?

Latest-biotech-pharma-news-updates-for-ajinomot-pfizer-ikena-lilly-bright-peak

Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing

transcatheter-aortic-valve-replacement-implantation-market-trends

Ever-Evolving Market Landscape of Transcatheter Aortic Valve Replacement

How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?

recent-pharma-happenings-for-asher-bio-roche-novartis-epimab

Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand hits goal in phase 3; EpimAb raises $120M in Series C

Chronic Pain Market Landscape | Chronic Pain Pipeline | Osteoarthritis

Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape

pharma-happenings-for-valo-health-ventyx-takeda-maverick-therapeutics

Valo Health receives $110M Series B Cognito’s therapy slows Alzheimer’s disease Ventyx Biosciences raises $114M Takeda expands immuno-oncology portfolio

fake-news-misinformation-in-the-healthcare-medical-health-sector

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Neurology

Sleep Disorders: An Emerging Public Health Issue

Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?

Amgen to acquire Rodeo for $55M; Novartis expands radioligand portfolio; Organon acquires Alydia for $240M; Forma announces positive FT-4202 dose levels

How Depression Is Eroding The Mental And The Physical Health Of The Society?

Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing

Ever-Evolving Market Landscape of Transcatheter Aortic Valve Replacement

How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?

Asher Bio raises $55M; Roche halts Huntington’s phase 3 trial; Novartis’ radioligand hits goal in phase 3; EpimAb raises $120M in Series C

More Views & Analysis

Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape

Valo Health receives $110M Series B Cognito’s therapy slows Alzheimer’s disease Ventyx Biosciences raises $114M Takeda expands immuno-oncology portfolio

Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization

Eating Disorders: What Happens When Stigma And Misconceptions Command The Health

The Burden And The Impact Of Mental Health Issues In Today’s Time

Biohaven’s Troriluzole Failure; Daiichi/ AZ’s Enhertu; Fujifilm & Manufacturing Spree; J&J’s Darzalex Faspro

The Obesity Pandemic: What can we do about it?

Ikena bags $120M; Terns raises $87M for NASH; Ribometrix Genentech Collaboration; Hologic acquires Biotheranostics

Subscribe to our Updates

Daily

Weekly

Monthly